Eli Lilly’s expanding US production and advancing pipeline offset near-term headwinds and support bullish conviction. Read ...

LLY's post-market drop offers investment potential with robust R&D, capex strategies, and strong cash flow, positioning it ...

Eli Lilly and Company (NYSE: LLY) today announced its financial results for the first-quarter of 2025.

Learn more about the discovery of insulin and the controversy this life-saving medicine sparked.

More than 1,300 Florida A&M University students turned their tassels during the spring commencement at the Alfred Lawson Jr.

Lilly, which has its headquarters in Indianapolis, first announced that it would be seeking approval from Limerick City and ...

In 2023, experts decided against adding obesity drugs to the World Health Organisation's essential medicines list.

In this week’s S&P 500 healthcare earnings roundup, 21 of 24 companies beat earnings expectations, while three fell short. On ...

A new nonstop connection between Indianapolis and Dublin, Ireland, will begin flying out of the Indianapolis International ...

Telehealth company Ro will offer single-dose vials of Eli Lilly's obesity therapy Zepbound in an expansion of the ways patients with a prescription can access the drug. The agreement means Ro has ...

Lilly, meanwhile, is developing a triple receptor agonist, retatrutide, that targets GLP-1, GIP, and glucagon and is also in phase 3. Shares in Eli Lilly rose sharply in pre-market trading today ...